Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis

被引:8
|
作者
Tortelli, R. [1 ]
Arcuti, S. [2 ]
Copetti, M. [2 ]
Barone, R. [1 ]
Zecca, C. [1 ]
Capozzo, R. [1 ]
Barulli, M. R. [1 ]
Simone, I. L. [3 ]
Logroscino, G. [1 ,3 ]
机构
[1] Univ Bari A Moro, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Pia Fdn Card G Panico, Lecce, Italy
[2] IRCCS Casa Sollievo Sofferenza, Unit Biostat, Foggia, Italy
[3] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
来源
ACTA NEUROLOGICA SCANDINAVICA | 2018年 / 138卷 / 01期
关键词
amyotrophic lateral sclerosis; pseudobulbar affect; survival; DISEASE PROGRESSION; ALS; NEUROLOGY; COGNITION; SURVIVAL; LABILITY;
D O I
10.1111/ane.12918
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveTo evaluate whether the presence of pseudobulbar affect (PBA) in an early stage of the disease influences survival in a population-based incident cohort of amyotrophic lateral sclerosis (ALS). MethodsIncident ALS cases, diagnosed according to El Escorial criteria, were enrolled from a prospective population-based registry in Puglia, Southern Italy. The Center for Neurologic Study-Lability Scale (CNS-LS), a self-administered questionnaire, was used to evaluate PBA. Total scores range from 7 to 35. A score 13 was used to identify PBA. Cox proportional hazard models were used for survival analysis. The modified C-statistic for censored survival data was used for models' discrimination. RECursive Partitioning and AMalgamation (RECPAM) analysis was used to identify subgroups of patients with different patterns of risk, depending on baseline characteristics. ResultsWe enrolled 94 sporadic ALS, median age of 64years (range: 26-80). At the censoring date, 65 of 94 (69.2%), 39 of 60 (65.0%), and 26 of 34 (76.5%) patients reached the outcome (tracheotomy/death), in the whole, non-PBA and in the PBA groups, respectively. Kaplan-Meier survival curves for the two subgroups were not significantly different (log-rank test: 1.3, P=.25). The discrimination ability of a multivariable model with demographic and clinical variables of interest was not improved by adding PBA. In the RECPAM analysis, ALSFRSr and the total score of CNS-LS scale (</10) were the most important variables for differentiating all risk categories. ConclusionsThese preliminary results underlie that the presence of PBA at entry negatively influences survival in a specific subgroup of patients with ALS characterized by less functional impairment.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 50 条
  • [21] Differential effect of Dextromethorphan-Qunidine [DMQ] on tearfulness and laughter associated with pseudobulbar affect [PBA] in amyotrophic lateral sclerosis [ALS] patients
    Brooks, Benjamin Rix
    Bradley, Walter G.
    Arnold, Ryan
    Pope, Laura E.
    Berg, James E.
    Olney, Richard K.
    Smith, Richard A.
    ANNALS OF NEUROLOGY, 2006, 60 : S47 - S47
  • [22] The role of anxiety as a prognostic factor in amyotrophic lateral sclerosis
    Manera, Umberto
    Iazzolino, Barbara
    Peotta, Laura
    Canosa, Antonio
    Vasta, Rosario
    Palumbo, Francesca
    Torrieri, Maria Claudia
    Grassano, Maurizio
    Daviddi, Margherita
    Cabras, Sara
    Matteoni, Enrico
    Moglia, Cristina
    Calvo, Andrea
    Chio, Adriano
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [23] Prognostic models for amyotrophic lateral sclerosis: a systematic review
    Xu, Lu
    He, Bingjie
    Zhang, Yunjing
    Chen, Lu
    Fan, Dongsheng
    Zhan, Siyan
    Wang, Shengfeng
    JOURNAL OF NEUROLOGY, 2021, 268 (09) : 3361 - 3370
  • [24] Marital status is a prognostic factor in amyotrophic lateral sclerosis
    Spataro, R.
    Volanti, P.
    Lo Coco, D.
    La Bella, V.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (06): : 624 - 630
  • [25] Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis
    Yongting Lv
    Hongfu Li
    Neural Regeneration Research, 2025, 20 (09) : 2556 - 2570
  • [26] Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis
    Lv, Yongting
    Li, Hongfu
    NEURAL REGENERATION RESEARCH, 2025, 20 (09) : 2556 - 2570
  • [27] Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis
    Turner, MR
    Bakker, M
    Sham, P
    Shaw, CE
    Leigh, PN
    Al-Chalabi, A
    AMYOTROPHIC LATERAL SCLEROSIS, 2002, 3 (01): : 15 - 21
  • [28] Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis
    Koerner, S.
    Kollewe, K.
    Ilsemann, J.
    Mueller-Heine, A.
    Dengler, R.
    Krampfl, K.
    Petri, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (04) : 647 - E52
  • [29] Clinical features of amyotrophic lateral sclerosis and their prognostic value
    Tard, C.
    Defebvre, L.
    Moreau, C.
    Devos, D.
    Danel-Brunaud, V.
    REVUE NEUROLOGIQUE, 2017, 173 (05) : 263 - 272
  • [30] Marital status is a prognostic factor In amyotrophic lateral sclerosis
    Spataro, R.
    La Bella, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 742 - 742